SWELL1 regulates skeletal muscle cell size, intracellular signalling, adiposity and glucose metabolism

  1. Ashutosh Kumar
  2. Litao Xie
  3. Chau My Ta
  4. Antentor O Hinton Jnr
  5. Susheel K Gunasekar
  6. Rachel A Minerath
  7. Karen Shen
  8. Joshua M Maurer
  9. Chad E Grueter
  10. E Dale Abel
  11. Gretchen Meyer
  12. Rajan Sah  Is a corresponding author
  1. Washington University, United States
  2. Washington University School of Medicine, United States
  3. University of Iowa, United States

Abstract

Maintenance of skeletal muscle is beneficial in obesity and Type 2 diabetes. Mechanical stimulation can regulate skeletal muscle differentiation, growth and metabolism, however the molecular mechanosensor remains unknown. Here, we show that SWELL1 (Lrrc8a) functionally encodes a swell-activated anion channel that regulates PI3K-AKT, ERK1/2, mTOR signaling, muscle differentiation, myoblast fusion, cellular oxygen consumption, and glycolysis in skeletal muscle cells. LRRC8A over-expression in Lrrc8a KO myotubes boosts PI3K-AKT-mTOR signaling to supra-normal levels and fully rescues myotube formation. Skeletal muscle targeted Lrrc8a KO mice have smaller myofibers, generate less force ex vivo, and exhibit reduced exercise endurance, associated with increased adiposity under basal conditions, and glucose intolerance and insulin resistance when raised on a high-fat diet, compared to WT mice. These results reveal that the LRRC8 complex regulates insulin-PI3K-AKT-mTOR signalling in skeletal muscle to influence skeletal muscle differentiation in vitro and skeletal myofiber size, muscle function, adiposity and systemic metabolism in vivo.

Data availability

We have uploaded the RNA sequencing data file in GEO (accession code: Series GSE156667 )

The following data sets were generated

Article and author information

Author details

  1. Ashutosh Kumar

    Department of Internal Medicine, Cardiovascular Division, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Litao Xie

    Department of Internal Medicine, Cardiovascular Division, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Chau My Ta

    Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Antentor O Hinton Jnr

    Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa city, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Susheel K Gunasekar

    Department of Internal Medicine, Cardiovascular Division, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Rachel A Minerath

    Fraternal Order of Eagles Diabetes Research Center, Division of Cardiology, University of Iowa, Iowa city, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Karen Shen

    Program in Physical Therapy and Departments of Neurology, Biomedical Engineering and Orthopedic Surgery, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Joshua M Maurer

    Department of Internal Medicine, Cardiovascular Division, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Chad E Grueter

    Fraternal Order of Eagles Diabetes Research Center,Division of Cardiology, University of Iowa, Iowa city, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. E Dale Abel

    Fraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, University of Iowa, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5290-0738
  11. Gretchen Meyer

    Program in Physical Therapy and Departments of Neurology, Biomedical Engineering and Orthopedic Surgery, Washington University, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Rajan Sah

    Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, United States
    For correspondence
    rajan.sah@wustl.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1092-1244

Funding

National Institutes of Health (1R01DK106009)

  • Rajan Sah

National Institutes of Health (R01HL125436)

  • Chad E Grueter

National Institutes of Health (RO1HL127764)

  • E Dale Abel

National Institutes of Health (RO1HL112413)

  • E Dale Abel

National Institutes of Health (1P30AR074992-01)

  • Rajan Sah

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to the approved institutional animal care and use committee (IACUC) protocols of Washington University in St. Louis (20180217) and the University of Iowa (1308148).

Copyright

© 2020, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,044
    views
  • 626
    downloads
  • 46
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ashutosh Kumar
  2. Litao Xie
  3. Chau My Ta
  4. Antentor O Hinton Jnr
  5. Susheel K Gunasekar
  6. Rachel A Minerath
  7. Karen Shen
  8. Joshua M Maurer
  9. Chad E Grueter
  10. E Dale Abel
  11. Gretchen Meyer
  12. Rajan Sah
(2020)
SWELL1 regulates skeletal muscle cell size, intracellular signalling, adiposity and glucose metabolism
eLife 9:e58941.
https://doi.org/10.7554/eLife.58941

Share this article

https://doi.org/10.7554/eLife.58941

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.

    1. Cell Biology
    Weihua Wang, Junqiao Xing ... Zhangfeng Hu
    Research Article

    Existence of cilia in the last eukaryotic common ancestor raises a fundamental question in biology: how the transcriptional regulation of ciliogenesis has evolved? One conceptual answer to this question is by an ancient transcription factor regulating ciliary gene expression in both uni- and multicellular organisms, but examples of such transcription factors in eukaryotes are lacking. Previously, we showed that an ancient transcription factor X chromosome-associated protein 5 (Xap5) is required for flagellar assembly in Chlamydomonas. Here, we show that Xap5 and Xap5-like (Xap5l) are two conserved pairs of antagonistic transcription regulators that control ciliary transcriptional programs during spermatogenesis. Male mice lacking either Xap5 or Xap5l display infertility, as a result of meiotic prophase arrest and sperm flagella malformation, respectively. Mechanistically, Xap5 positively regulates the ciliary gene expression by activating the key regulators including Foxj1 and Rfx families during the early stage of spermatogenesis. In contrast, Xap5l negatively regulates the expression of ciliary genes via repressing these ciliary transcription factors during the spermiogenesis stage. Our results provide new insights into the mechanisms by which temporal and spatial transcription regulators are coordinated to control ciliary transcriptional programs during spermatogenesis.